Stem Cell Network Announces Competition for Stem-Cell Based Technologies or Therapies
Stem Cell Network announces funding competition for stem-cell based technologies or therapies
University of Toronto Professor Elected to U.S. National Academy of Engineering
University of Toronto professor elected as an international member of the U.S. National Academy of Engineering (NAE).
KITE Power Play Pitch Competition
Toronto Rehab Foundation, in partnership with KITE Research Institute, is hosting the second Power Play Pitch Competition.
New investments for Xpan Inc. and Nanology Labs
XPan Inc. and Nanology Labs receive new follow-on investments from FACIT.
VoxNeuro Announces Research Project with St. Joseph's Healthcare Hamilton
VoxNeuro’s Cognitive Health Assessments™ will be used alongside blood tests and various behavioural and clinical assessments to identify biomarkers of bipolar disorder.
Aspect Biosystems Announces US$20 Million Series A Financing
Fusion Pharmaceuticals receives investment commitment of up to US$20M
VBI Vaccines Announces Sci-B-Vac®Phase 3 Study Meets Primary and Secondary Endpoints
VBI Vaccines, a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, has reported that the Phase 3 study of its trivalent hepatitis B vaccine has met both primary and secondary endpoints for safety and efficacy.
Apply for the Canadian Technology Accelerator - Health Programs
The Trade Commissioner Service is currently recruiting for the Canadian Technology Accelerator cohort for life sciences start-ups and companies seeking to expand in the US and Asia.
Deep Genomics raises $40 million in Series B round
Toronto-based Deep Genomics, which has developed a platform that uses deep learning to create therapies, has closed a $40 million Series B round.
ProteinQure named one of CB Insights' Game Changers for 2020
ProteinQure, which has designed a platform to automate the computational design of protein-based drugs, has been named one of CB Insights’ Game Changers for 2020.
Synaptive Medical Announces Close of $25M Preferred Share Financing
Synaptive Medical, a Toronto-based medical and technology company solving surgical, imaging and data challenges, has completed a first round of investment totaling $25,000,000 USD.
Flosonics Medical Counts Down to Product Launch in Early 2020
Flosonics Medical, founded in February 2015, is focused on making a wearable ultrasound monitor to help clinicians with precision fluid management.
Bright Angel Therapeutics Announces New Funding to Advance Therapies for Invasive Fungal Infections
Bright Angel Therapeutics, a biotechnology company focused on developing novel antifungal drugs, today announced an extension to their seed financing round, adding funding that will enable continued advancement of their lead program targeting invasive and drug-resistant fungal infections.
Apply for Ontario Health Trade Mission to Korea and Japan
Apply for Ontario Health Trade Mission to Korea and Japan
Marion Surgical selected to join International and Export Development Program
Marion Surgical, which is building the world's first Virtual Reality Surgical Simulator, is one of the companies selected by the Canadian Digital Media Network, to join its Soft Landing program.
RetiSpec wins iGan Partners' Pitch to Heal Event
RetiSpec was selected as the winner of iGan Partners’ annual Pitch to Heal Event.

OBIO 2019 Annual Public Meeting: Recap and Photo Gallery
The OBIO Annual Public Meeting took place on November 25 and included a celebration of 10 years of the organization’s contributions to Ontario’s health science sector and a look to the future with a presentation highlighting the emerging field of digital therapeutics.
KA Imaging Prepares to Enter the Health Care Market With Revolutionary Digital X-Ray Detector
Canadian manufacturer KA Imaging has managed to overcome the challenge of having soft-tissue differentiation and single exposure featured in the same digital X-ray detector. The company plans to present Reveal™ to the Health Care market next year. Reveal™ is the world’s first portable digital detector capable of separating different energy levels.

2020 OBIO Capital Access Advisory Program - Call for Applications
2020 Call for Applications - NOW OPEN. OBIO CAAP® is a unique, industry-led initiative that provides selected high-potential Ontario health science companies with mentoring, strategic guidance and access to an expansive network of health science industry experts and investors to enhance the ability of OBIO CAAP companies to secure financing.